PIAO YANG¹, MOHSEN SHEYKHHASAN^2,*, REZA HEIDARI³, MOHSEN CHAMANARA^4,5, PAOLA DAMA⁶, AMIRHOSSEIN AHMADIEH-YAZDI⁷, HAMED MANOOCHEHRI⁸, HAMID TANZADEHPANAH⁹, HANIE MAHAKI¹⁰, NASER KALHOR¹¹, ASHKAN DIRBAZIYAN¹², SHARAFALDIN AL-MUSAWI¹³

Oncology Research, Vol.33, No.2, pp. 283-300, 2025, DOI:10.32604/or.2024.052939 - 16 January 2025

Abstract Cancer, a leading cause of global mortality, remains a significant challenge to increasing life expectancy worldwide. Forkhead Box R2 (FOXR2), identified as an oncogene within the FOX gene family, plays a crucial role in developing various endoderm-derived organs. Recent studies have elucidated FOXR2-related pathways and their involvement in both tumor and non-tumor diseases. Dysregulation of FOXR2 has been linked to numerous malignant tumors, spanning the brain, nervous system, thyroid, osteosarcoma, Hodgkin lymphoma, colorectal, liver, pancreatic, lung, breast, ovarian, prostate, female genital tract, endometrial, and uterine cancers. Despite extensive research on FOXR2 dysregulation, its practical applications More >

Sheng-Qiang Lu^*1, Yan Qiu^†1, Wei-Jie Dai^‡, Xiao-Yu Zhang^§

Oncology Research, Vol.25, No.5, pp. 681-689, 2017, DOI:10.3727/096504016X14771034190471

Abstract Forkhead box R2 (FOXR2), a member of the FOX gene family, has not been very well investigated for its role in cancer. A recent study has shown that FOXR2 is highly expressed in breast cancer samples and is associated with poor prognosis. In addition, FOXR2 was identified as an oncogene in medulloblastoma. Nevertheless, whether FOXR2 plays a role in colorectal cancer (CRC) remains unclear. In the present study, we conducted several in vitro and in vivo studies to investigate the expression and effect of FOXR2 in CRC. The study results demonstrated that FOXR2 was upregulated More >